NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines

NCT00777803 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

381

Enrollment

INDUSTRY

Sponsor class

Conditions

Glabellar Frown Lines

Interventions

DRUG: NT 201 (IncobotulinumtoxinA (Xeomin®/Bocouture®))
DRUG: OnabotulinumtoxinA (Vistabel®)

Sponsor

Merz Pharmaceuticals GmbH